BPH - Benign Prostatic Enlargement - Results from #60

A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study. October 6, 2024

Predictors of achieving a minimal clinically important difference in lower urinary tract symptoms 3 months after Rezum therapy. September 30, 2024

Cost Comparison of Prostatic Artery Embolization Between In-Hospital and Outpatient-Based Lab Settings. September 29, 2024

Postoperative urinary incontinence following BPH surgery: insights from a comprehensive national database analysis. September 29, 2024

Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. September 29, 2024

AI for BPH Surgical Decision-Making: Cost Effectiveness and Outcomes. September 23, 2024

Convective Water Vapour Energy Ablation (Rezum®) versus Prostatic Urethral Lift (Urolift®); A 2-Year Prospective Study. September 21, 2024

Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study. September 21, 2024

Propensity Score Matching Analysis of Differential Outcomes in Holmium Laser Enucleation of the Prostate vs. Robotic-Assisted Simple Prostatectomy. September 16, 2024

Impact of Preoperative Continence on HoLEP Symptom Recovery: A Close Investigation of Patient-Reported Outcomes. September 16, 2024

Efficiency of HoLEP in patients with detrusor underactivity and renal dysfunction secondary to BPO. September 15, 2024

Prostate MRI transitional zone volume predicts Benign Prostatic Hyperplasia enucleation volume better than alternative modalities. September 15, 2024

Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. September 15, 2024

5α-reductase inhibitors with or without alpha-blockers and risk of incident upper tract urothelial carcinoma in men with benign prostatic hyperplasia: Analysis of US insurance claims data. September 9, 2024

LUTS/BPH increases the risk of depressive symptoms among elderly adults: A 5-year longitudinal evidence from CHARLS. September 6, 2024

Functional outcomes following external beam radiation therapy for patients with prior holmium laser enucleation of the prostate. September 6, 2024

A comparison of the efficacy of dutasteride on reducing lower urinary tract symptoms among patients with small versus large benign prostatic hyperplasia. September 6, 2024

Establishing and characterizing the molecular profiles, cellular features, and clinical utility of a patient-derived xenograft model using benign prostatic tissues. September 6, 2024

Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia. September 2, 2024

Transurethral Resection of the Prostate (TURP) and concomitant inguinal hernioplasty: a single-center experience. September 2, 2024

Page 4 of 142